Guangsu Zhu

Title: Innovations of Guangsu Zhu in Metabolic Disorders

Introduction

Guangsu Zhu is a notable inventor based in Guangdong, China. He has made significant contributions to the field of metabolic disorders through his innovative research and patents. His work focuses on improving health outcomes related to metabolic syndrome and other related conditions.

Latest Patents

Guangsu Zhu holds a patent for a strain known as CCFM8631. This strain has been shown to significantly increase the neurotransmitter 5-hydroxytryptamine level in peripheral blood. It also aids in recovering hormone levels, such as testosterone, in rats. The strain normalizes the abundances of various genera in the intestinal flora of rats affected by a high-fat, high-starch diet. Additionally, it demonstrates good tolerance to simulated gastrointestinal fluid and quickly colonizes the intestinal tract. The strain significantly improves pathological damages to tissues, including the liver and duodenum, and enhances triglyceride and total cholesterol levels in serum, as well as oral glucose tolerance in rats with metabolic syndrome.

Career Highlights

Guangsu Zhu is associated with Infinitus (China) Company Ltd., where he continues to advance his research. His innovative work has the potential to prevent, relieve, or treat metabolic disorders, including metabolic syndrome, irritable bowel syndrome, and mental diseases related to metabolic syndrome, such as anxiety and depression.

Collaborations

He collaborates with notable colleagues, including Fangli Ma and Wei Feng Chen, to further enhance the impact of his research and innovations.

Conclusion

Guangsu Zhu's contributions to the field of metabolic disorders through his patent and research are noteworthy. His work not only addresses significant health issues but also paves the way for future innovations in the treatment of metabolic conditions.